 we report on our financial results for the third quarter of fiscal 2022 and discuss our plans for the remainder of the year and the outlook for the future. 
 we also discuss the impact of our recent acquisition of Thrive and the outlook for our international medical business.    
 # 1_#1 _ # 1_#1 _ =    # 1 1.25 in.125 in.25 in 